Narrative identity, rationality, and microdosing classic psychedelics
This interview study (n=30) reviewed the experiences of subjects who have used psychedelics (e.g. LSD, psilocybin) in small quantities (microdosing) to understand their reasons and how they perceived themselves in their conventional lives in the context of their narrative identity. The study opined that the acute use of such psychedelics in small quantities allowed the subjects to rationalize their reasons due to their procurement and administration practices as well as health reasons. This helped them normalize their drug use, facilitated persistence and saw themselves as conventional citizens with middle-class values. This reasoning ultimately allows them to distance themselves from those who abuse psychedelics.
Authors
- Peter Hendricks
- Heith Copes
Published
Abstract
Background
Microdosing involves ingesting a small dose of a classic psychedelic (e.g., LSD and psilocybin) at regular intervals for prolonged periods. The practice is said to reduce anxiety, improve mood, and offer several creative and practical benefits to users. Using the narrative identity theoretical framework, our aim was to explore the experiences of those who microdosed classic psychedelics. Specifically, we sought to understand how and why they began microdosing and how they made sense of their actions in the context of their conventional lives.
Methods
To understand the experiences of those who microdose classic psychedelics, we rely on data collected from semi-structured interviews with 30 people who had microdosed.
Results
Participants saw themselves as conventional citizens who microdosed for rational and instrumental purposes. They emphasized the rationality of microdosing by discussing (1) the practicality of their procurement and administration processes, (2) the connection between their microdosing practice and their general awareness in health and wellness, and (3) the benefits of the practice.
Conclusion
Participants described their microdosing in the context of embracing traditional middle-class values. This created social distance between themselves and those who use drugs recreationally. While people who use drugs recreationally typically construct boundaries by distancing themselves from symbolic others (i.e., “crackheads,” “meth heads,” “junkies”), microdosers constructed boundaries by emphasizing connections to conventional citizens who embrace middle-class values. This connection to conventional citizens allows them to normalize their drug use and facilitates persistence.
Research Summary of 'Narrative identity, rationality, and microdosing classic psychedelics'
Introduction
Classic psychedelics such as LSD and psilocybin alter perception, mood and cognition, and recent scientific interest has focused on their therapeutic potential for conditions including end-of-life distress and addiction. In popular discourse there has been renewed attention to microdosing—regular ingestion of sub‑perceptual amounts of these substances—with users attributing improvements in mood, creativity and productivity to the practice, yet clinical evidence for these claims remains limited. Prior qualitative work has described motives and methods of microdosers but has not applied a theoretical identity framework to explain how people make sense of the practice within their everyday lives. Webb and colleagues set out to explore how people who microdose construct narratives about their practice using the narrative identity framework. The study aimed to understand why participants began microdosing, how they organised procurement and dosing, and how they reconciled microdosing with conventional social roles. To do this the investigators relied on semi‑structured interviews with 30 people who had engaged in microdosing, analysing how participants drew on cultural stories and symbolic boundaries when describing their behaviour.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Compounds
- Topics
- Authors
- APA Citation
Webb, M., Copes, H., & Hendricks, P. S. (2019). Narrative identity, rationality, and microdosing classic psychedelics. International Journal of Drug Policy, 70, 33-39. https://doi.org/10.1016/j.drugpo.2019.04.013
References (6)
Papers cited by this study that are also in Blossom
Anderson, T., Petranker, R., Rosenbaum, D. et al. · Psychopharmacology (2019)
Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S. et al. · Journal of Psychopharmacology (2016)
Hendricks, P. S. · International Review of Psychiatry (2018)
Johnson, M. W., Garcia-Romeu, A., Johnson, P. S. et al. · Journal of Psychopharmacology (2017)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Johnstad, P. G. · Nordic Studies on Alcohol and Drugs (2018)
Cited By (24)
Papers in Blossom that reference this study
Joy Donegan, C., Daldegan-Bueno, D., Sumner, R. L. et al. · Therapeutic Advances in Psychopharmacology (2025)
Murphy, R. J., Wardlaw, M., Smith, T. et al. · Journal of Humanistic Psychology (2025)
Pop, I., Dinkelacker, J. · Nordic Studies on Alcohol and Drugs (2023)
Ryan, R. S., Copello, A., Fox, A. P. · BMC Psychiatry (2023)
Peterson, A., Largent, E. A., Sisti, D. et al. · AJOB Neuroscience (2022)
Kaypak, A. C., Raz, A. · Transcultural Psychiatry (2022)
Cavanna, F., Muller, S., de la Fuente, L. A. et al. · Translational Psychiatry (2022)
Rootman, J. M., Kiraga, M., Kryskow, P. et al. · Scientific Reports (2022)
Hartong, V., van Emmerik, A. · Journal of Psychoactive Drugs (2022)
Basedow, L. A., Kuitunen-Paul, S. · Drug and Alcohol Review (2022)
Show all 24 papersShow fewer
Polito, V., Liknaitzky, P. · Psyarxiv (2021)
Marschall, J., Fejer, G., Lempe, P. et al. · Journal of Psychopharmacology (2021)
Cavanna, F., Muller, S., de la Fuente, L. A. et al. · Translational Psychiatry (2021)
Rootman, J. M., Kryskow, P., Harvey, K. et al. · Scientific Reports (2021)
Dressler, H. M., Bright, S. J., Polito, V. · Journal of Psychedelic Studies (2021)
Pedersen, W., Copes, H., Gashi, L. · Acta Sociologica (2021)
Gashi, L., Sandberg, S., Pedersen, W. · International Journal of Drug Policy (2021)
Nichols, D. E., Walter, H. · Pharmacopsychiatry (2020)
Silver, L. S. · American Journal of Management (2020)
Kuypers, K. P. C. · Therapeutic Advances in Psychopharmacology (2020)
Rosenbaum, D., Weissman, C. R., Anderson, T. et al. · Journal of Psychopharmacology (2020)
Lea, T., Amada, N., Jungaberle, H. et al. · International Journal of Drug Policy (2020)
Hutten, N. P. W., Mason, N. L., Dolder, P. C. et al. · Frontiers in Psychiatry (2019)
Beaton, B., Copes, H., Webb, M. et al. · Journal of Drug Issues (2019)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.